Overstock.com’s CEO denied reports the company suffered any significant losses because of a glitch in cryptocurrency systems, and said that, despite the media coverage, he still believes Bitcoin holds a lot of potential for the company.
“Right now we’re doing a tZero ICO raising $300 million...People are telling me that’s a business they think has a 3 billion or 4 billion value,” Patrick Byrne told Cheddar Friday.
“I literally have people on Wall St. saying, if I pull off the tZero ICO, and then over two years we do what we think we can do, they say that’s a $40 billion enterprise. People have no idea, yet how much of the financial system we intend to augment.”
Reports emerged earlier this week that a bug created a big opportunity for arbitrage, allowing customers to purchase items with Bitcoin Cash, which trades at roughly $2,500, and return them in exchange for Bitcoin, priced at more than $13,000.
Byrne said the issue was caused by the overwhelming trade volume at payment partner Coinbase. He claims the mix-up, which lasted milliseconds, did not result in any material losses.
For full interview [click here](https://cheddar.com/videos/overstock-ceo-responds-to-bitcoin-mix-up).
A report shows that a majority of young adults get their money advice on social media. Kendall Meade, financial planner at SoFi, joined Cheddar News to explain how to vet economic tips on social media.
Ryan Begin, Divert's CEO and co-founder, joined Cheddar News after the company recently received $1 billion infrastructure development agreement with Enbridge to support its efforts to protect the value of food.
John Peyton, CEO, of Dine Brands, parent company of IHOP and Applebee's, joined Cheddar News to discuss the company's latest earnings results and venture into fast casual with the acquisition of Fuzzy’s Taco Shop.
There were a record 2.6 million weddings in 2022, which is up from 1.9 million in 2021 and 1.3 million in 2020, according to a report from The Knot, a wedding planning agency.
In line with a Biden administration proposal, pharmaceutical giant Eli Lilly is cutting the price of its most commonly prescribed insulins by 70 percent and capping out-of-pocket costs at $35 or less per month.
